CNTB logo

CNTB

Profile

Full Name

Connect Biopharma Holdings Limited

Ticker Symbol

CNTB

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

March 19, 2021

Indexes

Not included

Website

http://www.connectbiopharm.com

Employees

62

Key Details

Price

$0.83(0.00%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$26.03M

Annual EPS

-$0.28(+75.22% YoY)

PE ratio

-

Next earnings date

Apr 16, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.83
CNTB price is $0.83

30-Day Relative Volume

1.19
CNTB 30-day relative volume is 1.19

Price Performance

Price Today change

0%
CNTB {parameterFullLabel} is unchanged today

Price YTD change

-39.86%
CNTB price is down -39.86% since January 1st

Price 1-year change

-52.02%
CNTB price is down -52.02% year-on-year

Price 3-year change

-70.98%
CNTB price is down -70.98% over the past 3 years

Price Range

Price All-time high

$29.27
CNTB price is currently -97.16% below its historical high of $29.27

Price 3-year low

$0.51
CNTB price is currently +62.75% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$45.94M
CNTB market capitalization is $45.94 million

Market cap 3-year change

-70.84%
CNTB market capitalization is down -70.84% over the past 3 years

Market cap All-time high

$1.64B
CNTB market capitalization is currently -97.20% below its historical high of $1.64 billion

Market cap sector rank

37.09%
CNTB market capitalization is higher than 37.09% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.45%
CNTB shares outstanding is up +0.45% year-on-year

Shares Outstanding 3-Year Change

+0.5%
CNTB shares outstanding is up +0.5% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.71
CNTB beta is 0.71

200-day SMA

$1.08
CNTB price is currently -22.86% below its 200-day simple moving average

50-day SMA

$0.81
CNTB price is currently +2.82% above its 50-day simple moving average

RSI

60.53
CNTB 14-day relative strength index is 60.53

Volume

1.19
CNTB 30-day relative volume is 1.19

ATR

$0.11
CNTB average true range is $0.11

10-day Historical Volatility

156.15%
CNTB 10-day historical volatility is 156.15%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$26.03M
CNTB annual revenue is $26.03 million

Revenue Analysts estimate

-
CNTB annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
CNTB annual revenue 1-year change is unknown

Revenue Sector rank

36.98%
CNTB annual revenue is higher than 36.98% of companies in Healthcare sector

EPS

EPS

-$0.28
CNTB annual earnings per share is -$0.28

EPS Analysts estimate

-$0.97
CNTB annual earnings per share is currently -71.28% lower than the consensus analysts' forecast

EPS 1-year change

+75.22%
CNTB annual earnings per share is up +75.22% year-on-year

EPS Sector rank

75.48%
CNTB annual earnings per share is higher than 75.48% of companies in Healthcare sector

Profit

Gross profit

-
CNTB annual gross profit value is unknown

Gross margin

-
CNTB annual gross profit margin value is unknown

Operating profit

-$22.45M
CNTB annual operating income is -$22.45 million

Operating margin

-86.24%
CNTB annual operating profit margin is -86.24%

Net income

-$15.63M
CNTB annual net profit is -$15.63 million

Net margin

-60.03%
CNTB annual net profit margin is -60.03%

Expenses

Total expenses

$48.48M
CNTB annual total expenses is $48.48 million

Operating expenses

$48.48M
CNTB annual total operating expenses is $48.48 million

Cost of goods sold

-
CNTB annual cost of goods sold value is unknown

Selling, general & administrative expenses

$19.23M
CNTB annual SGA is $19.23 million

Depreciation and amortization

$660.00K
CNTB annual depreciation & amortization is $660.00 thousand

Interest expense

-
CNTB annual interest expense value is unknown

Income tax

$223.00K
CNTB annual income tax is $223.00 thousand

EBIT & EBITDA

EBIT

-$22.45M
CNTB annual earnings before interest & taxes is -$22.45 million

EBITDA

-$21.79M
CNTB annual EBITDA is -$21.79 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$101.28M
CNTB annual total assets is $101.28 million

Non current assets

$4.32M
CNTB annual long term assets is $4.32 million

Current assets

$96.96M
CNTB annual total current assets is $96.96 million

Cash and cash equivalents

$78.23M
CNTB annual cash & cash equivalents is $78.23 million

Accounts receivable

$789.00K
CNTB annual accounts receivable is $789.00 thousand

Inventory

-
CNTB annual inventory value is unknown

Liabilities

Total liabilities

$9.12M
CNTB annual total liabilities is $9.12 million

Long term liabilities

$656.00K
CNTB annual total long term liabilities is $656.00 thousand

Current liabilities

$8.46M
CNTB annual total current liabilities is $8.46 million

Accounts payable

$342.00K
CNTB annual accounts payable is $342.00 thousand

Debt

Total debt

$178.00K
CNTB annual total debt is $178.00 thousand

Total debt 1-year change

-61.72%
CNTB annual total debt is down -61.72% year-on-year

Long term debt

$24.00K
CNTB annual long term debt is $24.00 thousand

Short term debt

$154.00K
CNTB annual short term debt is $154.00 thousand

Equity & Capital

Shareholders equity

$92.17M
CNTB annual stockholders equity is $92.17 million

Book value

$92.17M
CNTB annual book value is $92.17 million

Retained earnings

-$345.36M
CNTB annual retained earnings is -$345.36 million

Working capital

$88.50M
CNTB annual working capital is $88.50 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$23.61M
CNTB annual cash flow from operations is -$23.61 million

Cash from operations 1-year change

+50.54%
CNTB annual cash flow from operations is up +50.54% year-on-year

Cash from investing

-$3.45M
CNTB annual cash flow from investing activities is -$3.45 million

Cash from investing 1-year change

-104.6%
CNTB annual cash flow from investing activities is down -104.6% year-on-year

Cash from financing

$227.00K
CNTB annual cash flow from financing activities is $227.00 thousand

Cash from financing 1-year change

+404.44%
CNTB annual cash flow from financing activities is up +404.44% year-on-year

CAPEX

CAPEX

$750.00K
CNTB annual capital expenditures is $750.00 thousand

CAPEX 1-year change

-
CNTB annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$24.36M
CNTB annual free cash flow is -$24.36 million

Free cash flow 1-year change

+49.06%
CNTB annual free cash flow is up +49.06% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
CNTB annual gross profit margin value is unknown

Operating margin

-86.24%
CNTB annual operating profit margin is -86.24%

Net margin

-60.03%
CNTB annual net profit margin is -60.03%

ROA & ROE

ROA

-15.43%
CNTB annual return on assets is -15.43%

ROE

-16.14%
CNTB annual return on equity is -16.14%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
CNTB price to earnings ratio value is unknown

PE ratio Sector rank

-
CNTB price to earnings ratio is unknown

PB Ratio

PB ratio

0.50
CNTB price to book ratio is 0.50

PB ratio Sector rank

29.79%
CNTB price to book ratio is higher than 29.79% of companies in Healthcare sector

PS Ratio

PS ratio

-
CNTB price to sales ratio value is unknown

PS ratio Sector rank

-
CNTB price to sales ratio is unknown

Enterprise value

Enterprise value

-$32.11M
CNTB enterprise value is -$32.11 million

Enterprise value Sector rank

2.65%
CNTB enterprise value is higher than 2.65% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
CNTB EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
CNTB EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

11.46
CNTB annual current ratio is 11.46

Quick ratio

-
CNTB annual quick ratio value is unknown

Leverage

Debt to equity

0.00
CNTB annual debt to equity ratio is 0.00

Interest coverage ratio

-
CNTB annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
CNTB piotroski f-score value is unknown

Altman Z-Score

-1.18
CNTB altman z-score is -1.18

Analyst ratings

Recent major analysts updates

Apr 1, 25 HC Wainwright & Co.
Buy
Mar 31, 25 HC Wainwright & Co.
Buy
Sep 6, 24 HC Wainwright & Co.
Buy
Jun 13, 24 HC Wainwright & Co.
Buy
Apr 17, 24 HC Wainwright & Co.
Buy
Mar 4, 24 HC Wainwright & Co.
Buy
Sep 13, 23 Cantor Fitzgerald
Overweight
Feb 8, 23 SVB Leerink
Outperform
Jun 2, 22 Cantor Fitzgerald
Overweight
May 5, 22 Piper Sandler
Neutral

Institutional Ownership

Similar stocks

IMRX logo
Immuneering (IMRX)
MAIA logo
MAIA Biotechnology (MAIA)
PRE logo
Prenetics Global Limited (PRE)
IMMX logo
Immix Biopharma (IMMX)
VRCA logo
Verrica Pharmaceuticals (VRCA)
RPTX logo
Repare Therapeutics (RPTX)
FBIO logo
Fortress Biotech (FBIO)
ECOR logo
electroCore (ECOR)
CCEL logo
Cryo-Cell International (CCEL)
  • What is the ticker symbol for Connect Biopharma Holdings Limited?
  • Does Connect Biopharma Holdings Limited pay dividends?
  • What sector is Connect Biopharma Holdings Limited in?
  • What industry is Connect Biopharma Holdings Limited in?
  • What country is Connect Biopharma Holdings Limited based in?
  • When did Connect Biopharma Holdings Limited go public?
  • Is Connect Biopharma Holdings Limited in the S&P 500?
  • Is Connect Biopharma Holdings Limited in the NASDAQ 100?
  • Is Connect Biopharma Holdings Limited in the Dow Jones?
  • When was Connect Biopharma Holdings Limited's last earnings report?
  • When does Connect Biopharma Holdings Limited report earnings?
  • Should I buy Connect Biopharma Holdings Limited stock now?

What is the ticker symbol for Connect Biopharma Holdings Limited?

The ticker symbol for Connect Biopharma Holdings Limited is NASDAQ:CNTB

Does Connect Biopharma Holdings Limited pay dividends?

No, Connect Biopharma Holdings Limited does not pay dividends

What sector is Connect Biopharma Holdings Limited in?

Connect Biopharma Holdings Limited is in the Healthcare sector

What industry is Connect Biopharma Holdings Limited in?

Connect Biopharma Holdings Limited is in the Biotechnology industry

What country is Connect Biopharma Holdings Limited based in?

Connect Biopharma Holdings Limited is headquartered in United States

When did Connect Biopharma Holdings Limited go public?

Connect Biopharma Holdings Limited's initial public offering (IPO) was on March 19, 2021

Is Connect Biopharma Holdings Limited in the S&P 500?

No, Connect Biopharma Holdings Limited is not included in the S&P 500 index

Is Connect Biopharma Holdings Limited in the NASDAQ 100?

No, Connect Biopharma Holdings Limited is not included in the NASDAQ 100 index

Is Connect Biopharma Holdings Limited in the Dow Jones?

No, Connect Biopharma Holdings Limited is not included in the Dow Jones index

When was Connect Biopharma Holdings Limited's last earnings report?

Connect Biopharma Holdings Limited's most recent earnings report was on Sep 5, 2024

When does Connect Biopharma Holdings Limited report earnings?

The next expected earnings date for Connect Biopharma Holdings Limited is Apr 16, 2025

Should I buy Connect Biopharma Holdings Limited stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page